HK Stock MarketDetailed Quotes

09966 ALPHAMAB-B

Watchlist
  • 4.670
  • +0.220+4.94%
Not Open Apr 26 16:08 CST
4.51BMarket Cap-19377P/E (TTM)

ALPHAMAB-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ALPHAMAB-B Earnings Date

Currency: CNY

Period

FY2023 Annual Report

Mar 28, 2024

Revenue(YoY)

218.77M

+31.12%
EPS(YoY)

-0.22

+36.25%
Analyst Rating

Buy

Apr 28, 2024

ALPHAMAB-B Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 28, 20202020/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
Aug 28, 20202020/Q20.000 / 0.000--

ALPHAMAB-B Earnings Reports

  • ALPHAMAB-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023

    Mar 28 09:50 ET

  • ALPHAMAB-B: DATE OF BOARD MEETING

    Mar 18 04:33 ET

  • ALPHAMAB-B: 2023 INTERIM REPORT

    Sep 28, 2023 04:32 ET

  • ALPHAMAB-B: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023

    Aug 23, 2023 09:48 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 28, 2024

    Buy

    • Strong Buy

      50.00%

    • Buy

      0.00%

    • Hold

      50.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    %Chg